U.S. Hospitality Stock News

Earlier this week, Alnylam Pharmaceuticals announced and presented new post hoc analyses from the HELIOS-B Phase 3 study of AMVUTTRA® (vutrisiran), revealing amyloid regression in 22% of treated patients and preservation of kidney function, with a consistent safety profile demonstrated among those with advanced chronic kidney disease. This reinforces AMVUTTRA’s established efficacy as a multi-organ RNAi therapeutic, potentially highlighting its differentiation in treating...

eXp World Holdings reported third quarter 2025 results showing a return to profitability with net income of US$3.5 million, 7% year-over-year revenue growth to US$1.32 billion, and declared a US$0.05 per share dividend for the fourth quarter, payable December 1, 2025. The company also introduced its AI-powered business assistant, Mira, and continued expanding both its international presence and agent network, signaling a focus on technology and global growth drivers. We'll examine how eXp's...

Joby Aviation and L3Harris Technologies recently completed the first flight of Joby’s hybrid-electric, autonomous vertical takeoff and landing demonstrator, targeting both defense and future commercial applications. This milestone marks Joby Aviation’s entry into hybrid powertrain technology, expanding its platform beyond all-electric air taxis and opening new opportunities in military logistics and extended-range air mobility. Let’s explore how this hybrid demonstrator milestone reshapes...

TTM Technologies recently reported that from July 1, 2025 to September 29, 2025, it did not repurchase any shares under its buyback program announced in May 2025, while management outlined expansion plans for advanced PCB manufacturing in China and a renewed focus on higher value-added segments during a non-deal roadshow. This renewed operational focus aligns with growing investor interest in value-oriented technology companies, particularly as industry caution mounts regarding...

Avadel Pharmaceuticals (AVDL) just announced third quarter and nine-month earnings results, showing a move from net losses to net income in both periods compared to last year. This jump highlights ongoing financial improvement and hints at a meaningful turnaround for the company. See our latest analysis for Avadel Pharmaceuticals. Shares of Avadel Pharmaceuticals have steadily gathered momentum in recent months, with a 30-day share price return of nearly 34% and a striking year-to-date gain...

Ever wondered if Uber Technologies is actually worth its current price, or if there is more value hidden in the stock than meets the eye? Uber’s stock has seen significant momentum, gaining 45.3% year-to-date and 217.8% over the past three years, despite a slight recent pullback. Recent headlines highlight Uber’s continued expansion efforts, with the company announcing a fresh partnership with businesses to broaden delivery services and deepen its presence across global markets. These...

Wondering if Deere is a smart buy at today’s price? You’re not alone, and knowing what’s fair value here could make all the difference for your portfolio. The stock has climbed an impressive 13.2% year-to-date and is up 21.6% over the past year, despite dipping slightly this week. Market buzz lately has focused on Deere’s push into precision agriculture technology and strategic partnerships. These moves have caught both investors' and industry watchers' eyes. These developments are shaping...

Central Bancompany (OTCPK:CBCY) just posted its earnings for the nine months ending September 2025. The company reported higher net interest income and net income compared to last year. Earnings per share also rose, reflecting ongoing operational improvements. See our latest analysis for Central Bancompany. Central Bancompany’s latest financial update arrives amid a breakout period for its stock. The share price has surged 15% in the past month and is now up nearly 71% year-to-date, with a...

The market was pleased with the recent earnings report from Madison Square Garden Entertainment Corp. ( NYSE:MSGE...

Ball Corporation ( NYSE:BALL ) just reported healthy earnings but the stock price didn't move much. We think that...

The board of Myers Industries, Inc. ( NYSE:MYE ) has announced that it will pay a dividend of $0.135 per share on the...

Readers hoping to buy Rockwell Automation, Inc. ( NYSE:ROK ) for its dividend will need to make their move shortly, as...

It's been a pretty great week for Organon & Co. ( NYSE:OGN ) shareholders, with its shares surging 14% to US$7.62 in...

Despite an already strong run, Viavi Solutions Inc. ( NASDAQ:VIAV ) shares have been powering on, with a gain of 32% in...

Hancock Whitney (HWC) shares have experienced some mild swings this week, but without any headline-making catalyst to grab investors’ attention. For those tracking regional bank stocks, the recent moves provide a good reason to take a fresh look at Hancock Whitney’s performance and value trends. See our latest analysis for Hancock Whitney. After a steady climb earlier in the year, Hancock Whitney’s 1-year total shareholder return now stands at 2.05 percent, while year-to-date share price...

Viasat, Inc. ( NASDAQ:VSAT ) came out with its second-quarter results last week, and we wanted to see how the business...

Earlier this month, BridgeBio Pharma presented new clinical trial data at the American Heart Association Scientific Sessions and published in JAMA Cardiology, revealing that acoramidis significantly reduced all-cause mortality through 42 months in patients with variant transthyretin amyloid cardiomyopathy, with particularly pronounced benefits in the high-risk V142I genetic subgroup. This outcome marks the first report of such substantial, durable clinical benefit for a therapy in this...

Tutor Perini (TPC) recently saw its shares move following broader construction sector trends. Investors are keeping an eye on how shifts in project demand and infrastructure spending may affect the company’s growth and financial outlook. See our latest analysis for Tutor Perini. Although Tutor Perini shares have pulled back 11.5% over the past week, this comes after a remarkable run. The company boasts a 146.9% year-to-date share price return and an impressive 116.4% total return for...

On November 13, 2025, Progress Software introduced early access to Progress Agentic RAG for Sitefinity, a new enterprise-grade capability that integrates retrieval-augmented generation (RAG) AI and real-time content assembly within its content management system. This positions Progress Software as the first to offer a generative CMS with built-in, multilingual RAG capabilities for creating hyper-personalized web experiences driven by user prompts. We'll now explore how this breakthrough in...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Timken (TKR) shares have been under pressure after the company reported an average 4% annual drop in organic revenue over two years, highlighting ongoing difficulties within its core operations. Recent forecasts suggest that revenue growth will continue to trail sector peers. See our latest analysis for Timken. Timken’s share price has advanced 11.45% so far this year. However, the stock’s overall momentum has been muted compared to the broader market, with a 5.76% total shareholder return...

Snap (SNAP) shares have had a bit of a ride lately, with the price moving up around 8% over the past month and gaining 20% in the past 3 months. The company’s recent performance is drawing some second looks from investors who are eager to understand what is next. See our latest analysis for Snap. Looking beyond the recent rally, Snap’s 1-year total shareholder return of -20% shows that even with short bursts of momentum, the stock is still facing challenges. The past quarter’s 20% share price...

Amcor (NYSE:AMCR) has been generating buzz after releasing its latest quarterly earnings along with news of a higher quarterly dividend. These updates usually spark increased investor attention, especially when profitability and shareholder returns are on display. See our latest analysis for Amcor. Amcor’s recent boost to its quarterly dividend and solid earnings have put it back on investors’ radar, especially as the company finalized a reverse stock split at its latest AGM. Despite these...

Arcellx (ACLX) just released its third quarter earnings, reporting a bigger net loss than last year. Investors are also watching for updates from upcoming clinical data presentations at a major hematology conference in December. See our latest analysis for Arcellx. Arcellx’s share price has seen some volatility lately, reflecting a tug-of-war between concerns about deeper quarterly losses and optimism ahead of December’s pivotal clinical data presentations. While the stock has delivered an...